144 related articles for article (PubMed ID: 7542809)
21. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
23. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation.
Staatz C; Taylor P; Tett S
Nephrol Dial Transplant; 2001 Sep; 16(9):1905-9. PubMed ID: 11522877
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients.
MacFarlane GD; Venkataramanan R; McDiarmid SV; Pirsch JD; Scheller DG; Ersfeld DL; Fitzsimmons WE
Pediatr Transplant; 2001 Apr; 5(2):119-24. PubMed ID: 11328550
[TBL] [Abstract][Full Text] [Related]
25. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
Rostaing L; Cointault O; Marquet P; Josse AG; Lavit M; Saint-Marcoux F; Kamar N
Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.
Gonschior AK; Christians U; Winkler M; Linck A; Baumann J; Sewing KF
Clin Chem; 1996 Sep; 42(9):1426-32. PubMed ID: 8787699
[TBL] [Abstract][Full Text] [Related]
27. Weight-based tacrolimus trough concentrations post liver transplant.
Liu Z; Cheng J; Powell E; Macdonald G; Fawcett J; Lynch S; Martin J
Intern Med J; 2019 Jan; 49(1):79-83. PubMed ID: 30043532
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Maciej K; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2018 Sep; 50(7):2235-2239. PubMed ID: 30177142
[TBL] [Abstract][Full Text] [Related]
29. Changes in tacrolimus distribution in blood and plasma protein binding following liver transplantation.
Zahir H; McCaughan G; Gleeson M; Nand RA; McLachlan AJ
Ther Drug Monit; 2004 Oct; 26(5):506-15. PubMed ID: 15385833
[TBL] [Abstract][Full Text] [Related]
30. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
[No Abstract] [Full Text] [Related]
31. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
Hermida J; Tutor JC
Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
[TBL] [Abstract][Full Text] [Related]
32. Comparison of different assays for the quantitation of FK 506 levels in blood or plasma.
Winkler M; Christians U; Stoll K; Baumann J; Pichlmayr R
Ther Drug Monit; 1994 Jun; 16(3):281-6. PubMed ID: 7521978
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
[No Abstract] [Full Text] [Related]
34. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
Cogill JL; Taylor PJ; Westley IS; Morris RG; Lynch SV; Johnson AG
Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
[TBL] [Abstract][Full Text] [Related]
36. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS.
Stienstra NA; Sikma MA; van Dapperen AL; de Lange DW; van Maarseveen EM
Ther Drug Monit; 2016 Dec; 38(6):722-727. PubMed ID: 27805928
[TBL] [Abstract][Full Text] [Related]
37. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
Peng ZG; Tian J
Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
[TBL] [Abstract][Full Text] [Related]
38. Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring.
Jusko WJ
Ther Drug Monit; 1995 Dec; 17(6):596-601. PubMed ID: 8588227
[TBL] [Abstract][Full Text] [Related]
39. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.
MacFarlane GD; Scheller DG; Ersfeld DL; Shaw LM; Venkatarmanan R; Sarkozi L; Mullins R; Fox BR
Clin Chem; 1999 Sep; 45(9):1449-58. PubMed ID: 10471647
[TBL] [Abstract][Full Text] [Related]
40. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
Tomita T; Homma M; Yuzawa K; Ohkohchi N; Hori T; Kaneko M; Hasegawa Y; Kojima H; Nagasawa T; Kohda Y
Ther Drug Monit; 2005 Feb; 27(1):94-7. PubMed ID: 15665753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
